返回
Guerbet SA（GURBF）价格
GURBF 股价走势图
GURBF 收益
Guerbet SA
$22.25
0%
$0
收盘价：Jan 16, 16:00:00 GMT-5
$22.25
0%
$0
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$22.25
开盘价
--
当日区间
-
52周范围
$22.25 - $22.25
交易量
--
平均成交量
0
每股收益（TTM）
--
股息收益率
--
市值
--
什么是 GURBF？
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,905 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.